Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1786 of 5804
-
New sickle cell drug DISC-3405 enters early human safety trial
Disease control Recruiting nowThis is an open-label, multicenter, within-participant dose-escalation study examining up to 3 dose levels of DISC-3405 and will assess the safety, tolerability, PK, and PD of DISC 3405 in participants with sickle cell disease.
Phase: PHASE1 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Online sleep therapy may ease anxiety too
Symptom relief Recruiting nowThis project aims to elucidate whether CBCTi changes symptom severity or even remission of anxiety disorders as compared with a delayed-start control group. The investigators will use a delayed-start randomized controlled trial in a cohort of individuals with anxiety and insomnia…
Phase: NA • Sponsor: Woolcock Institute of Medical Research • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Robot arm takes on colon surgery: faster, safer removal of growths?
Symptom relief Not yet recruitingThis study aims to compare the outcomes of Simplified Robot (FASTER) assisted Endoscopic Submucosal Dissection (ESD) with conventional ESD in the treatment of colorectal lesions. Using a prospective, single-center, randomized controlled design, the investigators will systematical…
Phase: NA • Sponsor: Kaiyun Liu • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Muscle-Saving supplement tested in kidney patients
Disease control Recruiting nowChronic kidney disease (CKD) complicates many pathologies and the rapid increase in its prevalence constitutes a major public health concern. Whatever the cause of kidney failure, high protein consumption is a factor of progression to end-stage kidney disease. A low-protein (0.6 …
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can extra antibodies keep myeloma patients safer on powerful new drugs?
Disease control Recruiting nowBispecific antibody therapies targeting BCMA (B-cell maturation antigen) represent a novel therapeutic approach for patients with multiple myeloma. They are currently used in cases of refractory multiple myeloma but are also being investigated in earlier lines of treatment. Howev…
Phase: PHASE4 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
100,000 volunteers sought for landmark ageing study
Knowledge-focused Not yet recruitingHealthspan Connect is a new research programme designed to understand what helps people stay healthy as they age. The programme will explore how lifestyle, environment, genetics, and social factors influence healthy ageing and overall wellbeing. The programme will recruit partic…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Lymph drainage may cool overactive immune response in sepsis
Disease control Recruiting nowTo demonstrate that external drainage of thoracic duct lymph during sepsis results in a reduction in circulating pro-inflammatory cytokines. To demonstrate safety and feasibility of early thoracic duct cannulation and external lymph drainage for up to 7 days in adult surgical in…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can an ultra-long-acting factor VIII simplify surgery for hemophilia a patients?
Knowledge-focused Recruiting nowHemophilia A is an inherited bleeding disorder caused by the absence or deficiency of coagulation factor VIII. The perioperative management of individuals with hemophilia A involves replacement therapies, typically through bolus or continuous infusions of Factor VIII, to ensure e…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Measles paradox: how a virus both wipes and boosts immune memory
Knowledge-focused Not yet recruitingMeasles is caused by measles virus (MeV). The disease is associated with lymphopenia and immune suppression, which is an important cause of measles-associated morbidity and mortality. Measles-induced immune suppression can last several years, whereas measles lymphopenia is usuall…
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Cancer patients who responded to sotorasib can keep taking it in this safety follow-up study
Disease control Recruiting nowThe primary objective of the study is to evaluate the safety and tolerability of the continuation of sotorasib with or without panitumumab and/or other anti-cancer therapies in participants continuing to derive benefit in Amgen-sponsored protocols.
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can group training or One-on-One counseling help kids with ADHD?
Symptom relief Not yet recruitingThe aim of the study is to compare the efficacy of The OutSMARTers program- an ADHD skills training group program for children aged 9-12 to customized individual counseling provided by a professional, The Kid Counseling Program. Approximately 100 children will be randomly assigne…
Phase: NA • Sponsor: University of Iceland • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could a heart drug tame pancreatitis? small trial aims to find out
Disease control Recruiting nowThe severity of hypertriglyceridemia induced acute pancreatitis (HTG-AP) is closely related to the serum triglyceride (TG) levels. The higher the TG levels, the greater the risk of developing severe acute pancreatitis (SAP). Previous expert consensus has pointed out that the key …
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New ultrasound trick could replace costly scans for common liver tumors
Diagnosis Recruiting now\[Background and Rationale\] Hepatic hemangioma is the most common benign tumor of the liver, with a reported prevalence of up to 20% in the general population. On B-mode ultrasonography, a typical hemangioma appears as a well-defined hyperechoic lesion compared with the surround…
Sponsor: Yonsei University • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
Simple monthly ECG could catch hidden heart rhythm disorder in seniors
Diagnosis ENROLLING_BY_INVITATIONThis prospective, single-arm study will evaluate the feasibility and yield of monthly, in-clinic 12-lead electrocardiogram (ECG) screening performed at affiliated Family Health Centers (Aile Sağlığı Merkezleri; ASMs) in Ordu, Türkiye, among community-dwelling adults aged ≥65 year…
Sponsor: Kotyora Family Medicine Health Management and Education Association • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Which additive works best for pain control in brain surgery?
Symptom relief Recruiting nowSupratentorial brain tumor surgeries are associated with significant nociceptive stimulation and postoperative pain, which may adversely affect patient outcomes. Scalp block has emerged as an effective regional anesthetic technique to improve analgesia and reduce opioid consumpti…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Gene mutation may unlock L-Carnitine's power for sperm health
Disease control OngoingInfertility remains a significant global burden. Estimates suggest that 10-15% of couples worldwide experience infertility, with male infertility being the underlying cause in 20-50% of cases. For the majority of cases however the etiology remains unknown, and is termed idiopathi…
Phase: PHASE3 • Sponsor: South Valley University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could fewer infusions tame thyroid eye disease?
Disease control Not yet recruitingThe goal of this interventional study is to compare the clinical outcomes of shortened 4-infusion course versus the standard 8-infusion course of Teprotumumab (Tepezza) in patients with active Thyroid Eye Disease (TED). The main question it aims to answer is: \* Is a shorter co…
Phase: PHASE4 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Which surgery is best for 2-3 cm kidney stones? major trial aims to find out
Disease control Not yet recruitingThis multicenter, prospective, randomized clinical trial compares FANS-assisted flexible ureteroscopy (FURS) with suction-assisted mini-percutaneous nephrolithotomy (mini-PCNL) for the treatment of renal stones measuring 2-3 cm. A total of 280 patients will be enrolled across nin…
Phase: NA • Sponsor: Mansoura University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Your smartwatch could help save hearts: new study lets you donate data for fairer prevention
Knowledge-focused Not yet recruitingCardiovascular disease (CVD) is the leading cause of death in the Netherlands and worldwide. While prevention strategies have improved, many population groups, including women, individuals with a migration background, and people with lower socioeconomic status, remain underrepres…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Placenta patch may heal stubborn leg wounds
Disease control Not yet recruitingThe purpose of this study is to determine how well our dHPT (Dehydrated Human Placental Tissue) Product and Standard of Care work when compared to Standard of Care alone in achieving complete closure of venous leg ulcers.
Phase: PHASE4 • Sponsor: Cellution Biologics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC